Coverage
-
August 06, 2026
A New York federal judge has given his initial blessing to a $10 million deal that would end an investor-led securities fraud lawsuit against cannabis company Cronos Group Inc. and its executives, which accused them of artificially inflating company revenue by improperly recording "round-trip" transactions as sales.
6 other articles on this case.
View all »